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Genus Cryptosporidium includes around 30 known apicomplexan parasitic species which infect the gastrointestinal tract and 
rarely the respiratory system of more than 300 vertebrate animals. The immune response against infection by Cryptosporidium 
spp. includes all strata of innate and adaptive immunity with differences in their significance. The mucosal immunity, expressed 
predominantly by the “sentinel” role of epitheliocytes, is fundamental to the resistance against an infection (mainly via activation 
of the TLR4/NF-κB signalling axis). The vast array of epithelial chemokines and cytokines initiate the local inflammatory 
processes, attract effector cells and may directly suppress the parasite adhesion. The second line of defence includes IFN-γ-
production by the NK cells in combination with their innate cytotoxicity against the parasite and the infected epitheliocytes. 
The adaptive immunity against the parasite depends predominantly on cytotoxic CD4+ Th1-lymphocytes, which makes IFN-γ 
central to the acquired response too. CD8+ cells aid to some extent the activity of Th1-cells but their involvement is not decisive. 
While Cryptosporidium infection elicits the synthesis of specific serum and mucosal antibodies, the humoral immunity is of minor 
importance. In immunocompromised hosts, infants and malnourished children, the mild and usually self-limiting infection can 
become life-threatening or take a chronic course. It is the second leading cause of fatal diarrhoea in children and one of the major 
opportunistic pathogens in the continually expanding group of patients with immunodeficiencies and systemic chronic diseases. 
Unravelling the mechanisms of resistance against Cryptosporidium infection is fundamental for the successful prevention of the 
disease. Biomed Rev 2019;30:37-48
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INTRODUCTION
Genus Cryptosporidium includes around 30 known api-
complexan parasitic species which infect more than 300 
vertebrate animals. In humans, the disease is transmitted via 
a faecal-oral mechanism and is associated predominantly 
with two species C. hominis (anthroponotic) and C. parvum 
(zoonotic). Several other members of Cryptosporidium spp. 
(C. parvum, C. meleagridis, C. cuniculиs, C. canis, C. fe-
lis, et cetera) have also been recorded in humans, but their 
epidemiological	 and	 clinical	 significance	 is	minor	 (1).	 In	
2016 a meta-analysis of the Institute for Health Metrics and 
Evaluation at the University of Washington, Seattle estimated 
that cryptosporidiosis is the second leading cause of diarrheal 
infection	in	children	younger	than	five	years	worldwide	and	
leads to more than 60 000 fatalities annually (2). Moreover, 
the condition is underdiagnosed and unrecognised, and its 
impact on global children’s health, growth and development 
is severely underestimated (1, 2). 
Cryptosporidium species complete their entire life cycle 
in the covering epithelia of the gastrointestinal or respiratory 
tract of a single vertebrate host. The infection occurs upon 
the ingestion of viable oocyst from the environment. In the 
process of excystation, four infective motile sporozoites are 
released. The apical complex of the sporozoites adheres to the 
epithelial plasmalemma, and via multiple signalling pathways 
induces a rearrangement of the host’s actin cytoskeleton, and 
parasite internalisation (1, 3). The resulting reorganisation of 
the host-parasite interface leads to the formation of a unique 
structure – a parasitophorous vacuole, a compartment where 
Cryptosporidium sporozoites and all subsequent stages of the 
life cycle reside. Therefore, the parasite inhabits a place in the 
cell that is distinctly separated from both the intestinal lumen 
and the host’s cytoplasm. This unique intracellular and yet 
extracytoplasmic position of the pathogen protects it against 
the host’s immune responses and plausibly contributes to the 
antimicrobial drug resistance (1, 4, 5). 
	Since	the	first	studies	of	cryptosporidiosis	in	humans	in	the	
last decades of the 20th century, the importance of a properly 
functioning immune system became apparent for the severity 
and the propagation of the ongoing infection. Subsequently, 
many researchers have attempted to uncover the intriguing 
mechanisms of interaction between the parasite and its host’s 
defence systems. 
The present review aims to summarise the current 
evidence from a plethora of immunological in vitro and 
in vivo studies about the role of the innate and adaptive 
response in the resistance against the infection caused by 
the Cryptosporidium spp.
THE INNATE RESPONSE OF INTESTINAL MUCOSA 
As mentioned earlier, all parasitic stages of Cryptosporidium 
spp. are localised in the epithelial lining of the gastrointestinal 
and (more rarely) pulmonary systems. The apical compartment 
of the epithelial cell is the only affected structure in the host 
organism. Consequently, the Cryptosporidia	are	classified	as	
one of the “minimally invasive” pathogens. That is why the 
innate immune reactions of the epithelial cells are crucial for 
the host’s resistance against this infection (4, 5).
The	first	contact	between	the	Cryptosporidium sporozoites 
and the epithelial cell induces an intracellular signalling 
cascade resulting in massive production of “alarming” 
cytokines	 (IL-8,	TNF-α	and	IL-1β)	 that	are	 triggering	cell-
mediated immune reactions and phagocytes-dependent 
inflammation	 (Fig.	 1)	 (5,	 6).	 In	 experiments	with	 human	
gastrointestinal epithelial cell lines infected with C. parvum, 
the production of the powerful neutrophil attractant IL-8 
(CXCL-8) is substantially elevated (7). Infected epithelial 
cells	also	excrete	IL-18	that	acts	as	a	potent	IFN-γ-inducing	
factor (8). In neonatal murine models of C. parvum infection, 
the epithelial cells produce a broad range of chemokines of 
the CXC and CC classes (CCL2, CCL5, CXCL1, CXCL8, 
CXCL9, CXCL10 et cetera), which facilitate the recruitment 
of various immune cells to the mucosa (4,9,10). CXCL10 is 
one	of	 the	molecules	 that	play	 an	 important	 role	by	 IFN-γ	
dependent mobilisation of the dendritic cells (DCs) (9, 10).
Parallel with the cytokine and chemokine release, C. 
parvum infection of the epithelial cells induces the expression 
of intercellular adhesion molecule-1 (ICAM-1). In a model 
of cryptosporidiosis in human gastrointestinal epithelial 
cultures, Gong et al. detected a steady microRNA-controlled 
upregulation of ICAM-1 expression accompanied by increased 
adhesion of human immortalised T-cells to the infected cells 
(11).
The	massive	 production	 of	 proinflammatory	 cytokines	
and chemokines can be attributed to the activation of the 
Toll-like receptors (TLRs), part of the pattern recognition 
receptors group. Under experimental conditions, TLRs 2 
and 4 in Cryptosporidium infected epithelial cells lead to the 
production of a multitude of interconnected chemokines [IL-8 
(CXCL8),	MCP-1	(CCL2),	MIP-2α	(CXCL2)],	prostaglandin	
E2 et cetera) involved in the recruitment of immune cells in 
the intestinal wall (7, 10, 12). 
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The	TLR4/NF-κB	 signalling	 axis	 is	 one	 of	 the	most	
extensively studied transduction systems following C. 
parvum invasion of the enterocytes. The light-chain nuclear 
factor	 kappa	 (NF-κB)	 controls	 the	 expression	 of	 various	
genes	responsible	for	cell	differentiation,	 inflammation	and	
immune responses mainly by initialising the synthesis of a 
variety	 of	 pro-inflammatory	 cytokines	 -	TNF-α,	 IL-1β	 and	
IL-8	and	ICAM-1	(Fig.	1).	Activation	of	the	NF-κB	pathway	
in epithelial cells after the infection with Cryptosporidium 
spp. comprises of early and transient reaction against the 
lipopolysaccharides followed by “late” sustained response 
when the parasite-epithelial interface is completely formed 
(13–15). 
Another	 major	 and	 very	 interesting	 role	 of	 NF-κB	
produced by epithelial cells (and in later stages by activated 
B-lymphocytes) is its involvement in the apoptosis (5, 7, 13, 
14).	The	NF-κB	 triggers	 the	 synthesis	of	 a	variety	of	 anti-
apoptotic factors and postpones the cell death of the infected 
enterocytes	significantly.	On	the	contrary,	a	severely	enhanced	
Fas-mediated activation of caspase-3 in the adjacent uninfected 
Figure 1. Main mechanisms of innate response to Cryptosporidium infection. The contact of the parasite with toll-like re-
ceptors (TLR) on the epithelial cells (Epi) plasmalemma triggers a cascade resulting in the massive production of antimicro-
bial peptides, cytokines and cell adhesion molecules. NK-cells (NK) and macrophages (Ma), recruited to the site of infection, 
exert their cytotoxic activity predominantly via IFN-γ production. Activated dendritic cells (DC) support the process through 
continuous secretion of proinflammatory cytokines.
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cells elicits the pathomorphological changes observed in 
the intestinal mucosa (7, 13, 14). This protection of the 
Cryptosporidium infected cells from apoptosis is vital for the 
parasite survival and the propagation of the infection, and one 
of the primary mechanisms for evasion of host immunity and 
defence (7, 10, 13, 14). 
The enterocytes produce a variety of antimicrobial peptides 
(e.g. defensins), that can penetrate the cell wall of protozoal 
and bacterial cells, directly killing the pathogens. C. parvum 
selectively	up-regulates	human	β-defensin1	and	-2	peptides	
(via TLRs mediated signals) leading to the prevention of the 
in vitro development of the Cryptosporidium sporozoites or 
their direct destruction (10, 14).
Thus, epithelial cells play a crucial role in the resistance 
against	cryptosporidiosis	by	triggering	inflammatory	responses	
and mobilisation of leukocytes from the connective tissue and 
circulation, and cytokine related local parasitotoxic reactions. 
However, there is a notable difference in the responses of in 
vitro epithelial cell lines as compared to the reactions of the 
mucosa in the infected animal and human hosts (10). This 
observation warrants a more in-depth analysis of the signalling 
pathways involved in the complex interaction between 
Cryptosporidia, epithelial cells and surrounding tissues.
The natural cytotoxicity of the natural killer (NK) cells 
is just a part of their intricate involvement in the innate 
reaction against intracellular microorganisms (parasites, 
bacteria and viruses). NK lymphocytes express a complex 
array of activating (e.g. IL-2R, IL-12R, IL-18R et cetera) 
and dampening (e.g. inhibitory MHC class I) receptors, 
which	regulate	their	cytopathic	effect	and	recognise	specific	
ligands produced by the infected or damaged cells. After 
activation, NK cells exert cytotoxic activity either via the 
release of directly cytolytic substances (e.g. perforin, granzyme 
B, FasL et cetera), activation of death receptors and the 
external apoptotic way in target cells or indirectly through 
the	production	of	various	cytokines	–	predominantly	TNF-α, 
IFN-γ,	GM-CSF	et cetera (16). Experiments have shown that 
murine lines with a mutation leading to a defect in the natural 
cytotoxicity of NK cells have a more severe manifestation of 
C. parvum infection as compared to wild type (6). Multiple 
immunological studies demonstrate that the resistance against 
C. parvum	infection	is	mostly	IFN-γ-dependent	(4,	7,	17–20).	
Thus, the NK cells may exhibit their anti-Cryptosporidium 
function	via	 the	 substantial	 release	of	 IFN-γ	 (Fig.	 1).	This	
conclusion	is	supported	by	evidence	of	amplified	cytotoxicity	
of the NK cells against C. parvum-infected human enterocytes, 
especially after incubation with IL-15 (a cytokine responsible 
for NK maturation and activation) (6, 20). 
A subject of substantial interest is how C. parvum is 
presented to the cells of the adaptive immunity if it occupies 
only the parasitophorous vacuole in the apical part of the 
enterocytes and does not infect deeper layers of the mucosa. 
Despite that, studies of biopsy materials from heavily infected 
AIDS-patients have shown the presence of C. parvum in 
M-cells,	DCs,	macrophages	 and	 other	 inflammatory	 cells	
which	 confirms	 their	 role	 as	 antigen-presenting	 structures	
(4, 21, 22). The involvement of the DCs in Cryptosporidium 
infection is still under investigation. Several studies 
demonstrate that when bone marrow DCs are exposed to 
sporozoites or cryptosporidium antigens, it induces their 
maturation	and	starts	the	production	of	IFN-α	and	-β,	IL-1β,	
IL-6 and IL-12 (10, 20). C. parvum-infected murine DCs 
quickly migrate to the site of infection and, once activated, 
relocate in the mesenteric lymph nodes (MLNs) (23). Some 
studies suggest that infected epitheliocytes themselves act as 
antigen-presenting cell or indirectly facilitate the process via 
the substantial array of produced cytokines and chemokines 
that recruit other immune cells (5). Another hypothesis is that 
the antigen presentation is triggered by the macrophages when 
they come to phagocytise the apoptotic bystander cells (5, 
13). Experiments with neonate mice infected with C. parvum 
have	 shown	a	60-fold	 rise	 in	 the	 inflammatory	monocytes/
macrophages, not only in lamina propria but also in the sub-
epithelium stratum, and the ability of those cells to migrate 
among the epitheliocytes and sample apoptotic material from 
the lumen (10). Several recent studies mutually suggest an 
essential protective mechanism against cryptosporidiosis in 
which the synergistic initiation of macrophages by IL-12 and 
IL-18 leads to the production of the vital cytokine IFN- γ	(4).
The activation of T-lymphocytes in the intestinal mucosa 
is a major part of the immune response and structurally takes 
place	 in	 three	 different	 locations.	The	 specific	 reactions	
against Cryptosporidium spp. are probably triggered in the 
Peyer’s patches, where M-cells transport the antigens to the 
DCs, which phagocytise and subsequently present them to 
the T-cells. Ultrastructural studies in guinea pigs show that 
Cryptosporidia invade the M-cells of the Peyer’s plaques. 
Parasites are even detected within the phagocytic cells under 
the mucosa (10, 21). In other experiments with mice infected 
with C. parvum a tenfold increase is observed in the numbers 
of T- and B- lymphocytes in the Peyer’s plaques and parasite’s 
antigens are detected even in remote MLNs (6). A more current 
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study demonstrates that even living C. parvum forms can be 
detected in the MLNs,	verified	by	the	existence	of	parasitic	
mRNA (23). 
Lamina propria is the second important location of antigen 
presentation as proven by the serious increase in the lymphocyte 
populations in the regions overlaid by cryptosporidium invaded 
enterocytes (24). Furthermore, the recovery of patients with 
AIDS and chronic diarrhoea on highly active antiretroviral 
therapy (HAART) coincides with the rapid increase in 
CD4+	 cells,	 specifically	within	 lamina propria (25). The 
importance of the intraepithelial lymphocytes in the control 
of	the	cryptosporidiosis	is	demonstrated	by	their	significant	
increase recorded in experimental studies in infected mice and 
cattle (7). Also,	severe	combined	immunodeficiency	(SCID)	
mice inoculated with intraepithelial lymphocytes from healthy 
donors previously infected with C. muris very quickly resolve 
the Cryptosporidium infection (4). 
Different studies are trying to estimate the role of other 
molecules and pathways, such as mucins, exosomes, 
complement system (C3, C4, and mannose-binding lectin), 
epithelial cytokines (IL-25, IL-33 and IL-34), serum amyloid 
A3, osteoprotegerin, thymic stromal lymphopoietin and 
others, proven to be necessary in the innate mucosal immunity 
against different microbial pathogens but the results are still 
preliminary,	 insufficient	and	sometimes	controversial	 (4,	5,	
7, 10, 26).
THE ROLE OF THE CYTOKINES 
The cytokines include numerous effector peptides secreted by 
a broad array of immunocompetent and other cells. Majority 
of these molecules are secreted by the cells of the innate 
immunity (epithelial cells, antigen-presenting cells, et cetera). 
Correspondingly, cytokine-related mechanisms are “switched 
on” in the earliest stages of the Cryptosporidium infection. 
Further on, antigen-activated CD4+ T-helper cells (as part 
of the adaptive immunity) also produce a diverse cocktail 
of	 cytokines	 related	 to	 the	 cell-mediated	 (IFN-γ,	 IL-2,	 and	
IL-12) and antibody-mediated (IL-4, IL-5, IL-6, and IL-10) 
immune responses. 
IFN-γ	(involved	in	both	innate	and	acquired	reactions)	plays	
the most important role in the suppression of Cryptosporidium 
reproduction and the regulation of the parasitic infection (4, 
5, 7, 10, 20, 27, 28). One of the most severe and ultimately 
fatal cases of cryptosporidiosis has been described in a child 
with	a	congenital	deficiency	in	the	synthesis	of	IFN-γ	(29).	
Various	 experiments	 in	 transgenic	murine	 lines	 confirm	 its	
extreme importance. Cryptosporidium	 infection	 in	 IFN-γ-
deficient	mice	results	in	persistent	diarrhoea,	which	is	even	
more severe than in CD4-knockouts (24). In other experiments, 
administration	of	IFN-γ-neutralizing	antibodies	to	mice	with	
SCID exacerbates the infection with C. parvum and reduces 
their	survival	significantly	(23,	30). A substantial correlation 
exists	between	the	kinetics	of	IFN-γ	and	the	course	of	the	acute	
cryptosporidiosis.	IFN-γ	levels	rise	and	reach	a	peak	in	parallel	
with the clinical symptoms, and decline sharply with the onset 
of	recovery	(8).	Despite	the	crucial	role	of	IFN-γ	in	the	early	
stages of immunological defence, most recent studies conclude 
that the ultimate resistance against cryptosporidiosis requires 
IFN-γ	as	well	as	normally	functioning	CD4	+	T-lymphocytes	
(4,	7).	Thus,	IFN-γ	probably	exerts	its	protective	effects	against	
cryptosporidiosis in the domain of the acquired immune 
responses.
Some authors even provide evidence for the existence 
of	 alternative	 (IFN-γ-independent)	 pathways.	Those	 are	
usually associated with increased production of IL-15 by the 
epitheliocytes of Cryptosporidium infected individuals (30). 
IL-15 levels correlate inversely with the parasite propagation. 
In vitro studies observe that IL-15 activates NK cells to 
eliminate intestinal Cryptosporidium infected epithelial cells 
(31).	Neither	IFN-γ	nor	IL-15	was	detected	in	the	intestinal	
epithelium of HIV+ patients with chronic and uncontrolled 
cryptosporidiosis (32). The relevant conclusion is that there 
are two separate innate (associated with IL-15) and adaptive 
(associated	with	 IFN-γ)	 immune	 responses	 involved	 in	 the	
resistance against cryptosporidiosis (7, 10).
IL-12 (major	inducer	of	IFN-γ	synthesis)	also	plays	a	central	
role in the acquired and innate protection. Experimental studies 
demonstrate that treatment of newborn immunocompromised 
mice with IL-12 before infection creates resistance to 
cryptosporidiosis while treatment with IL-12-neutralizing 
antibodies increases the severity of the disease (33).
Conflicting	 results	 follow	 the	 investigations	 on	 the	 role	
of IL-4. After stimulation with Cryptosporidium antigens, 
human	peripheral	mononuclear	cells	demonstrate	significant	
expression	of	both	IL-4	and	IFN-γ	(34).	Several	contradictive	
hypotheses suggested that IL-4 is either: (i) involved in the 
late stages of the infection; (ii) promotes DCs activation; (iii) 
facilitates the protective Th1 reactions; (iv) plays part in the 
immune memory or (vi) has suppressive or no role whatsoever 
in the immunity against cryptosporidiosis (4, 6).
The protective effect of another cytokine, IL-5, is 
confirmed	by	an	experiment	in	which	the	individual	classes	
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of interleukins are blocked separately, and the authors account 
for the number of Cryptosporidium oocysts released from the 
infected animals. Highest levels of oocysts’ production are 
reported in the experiments where both IL-4 and IL-5 were 




with C. parvum (6, 36). Mutant murine lines with reduced 
intestinal	TNF-α	production	 cannot	 limit	 cryptosporidiosis	
compared to wild controls, and the supplementation of this 
cytokine leads to a rapid resolution (36). The protective effect 
of	TNF-α	is	evident	from	several	studies	in	which	the	addition	
of	TNF-α	to	C. parvum-infected cell cultures of human and 
mouse enterocytes rapidly suppresses the parasite reproduction 
(27,37). 
Other	 proinflammatory	 cytokines	 (IL-1,	 IL-6)	 released	
by multiple immunocompetent cells exert protection even 
in	 the	absence	of	TNF-α	 (6).	 In	mouse	and	human	models	
of Cryptosporidium infection,	 IL-1	 levels	rise	significantly.	
Additionally, in vitro	experiments	have	confirmed	its	role	as	
an inhibitor of the parasite reproduction in human enterocyte 
cultures (27, 37). 
CYTOKINE-MEDIATED REACTIONS
The	proinflammatory	IFN-γ	and	TNF-α	initiate	the	pathogen	
destruction via the generation of toxic nitric oxide (NO) by-
products and oxygen radicals. Both cytokines (produced by 
the epithelial cells, active T-lymphocytes and NK cells), start 
the cascade of inducible nitric oxide synthase (iNOS) leading 
to the metabolization of arginine into NO and citrulline. In an 
experiment	with	athymic	nude	mice	artificially	supplemented	
with	arginine,	the	faecal	oocyst	shedding	is	significantly	lower	
compared to controls on a regular diet (38). The synthesis 
of NO also stimulates the expression of prostaglandin E2, 
which improves the barrier function of epitheliocytes by 
increasing their electrical resistance (39). Since the iNOS is 
activated very early during infection, this process should be 
considered (at least partially) an innate immune mechanism. 
While	several	authors	confirm	the	role	of	nitrogen	derivatives	
in the Cryptosporidium destruction, other studies demonstrate 
inconclusive or contradictive results (27, 37). 
The Cryptosporidium reproduction may be contained 
via	 additional	 IFN-γ	 induced	 mechanisms	 like	 the	
microenvironment depletion of essential metabolites (e.g. 
tryptophan or cellular iron) (27, 28). The direct effects of 
IFN-γ	 on	 the	 intestinal	 epithelium	may	 further	 inhibit	 the	
parasite invasion and its intracellular development (27). This 
vital mechanism of resistance to cryptosporidiosis is, however, 
still under investigation.
Many contemporary studies are trying to evaluate the 
involvement	of	other	pro-inflammatory	(IL-8,	IL-18)	and	anti-
inflammatory	(IL-10,	TGF-β)	cytokines	(4,	7,	10).	Probably	the	
resistance and the susceptibility to Cryptosporidia depends on a 
still	to	be	revealed	refined	equilibrium	between	the	synthesis	
of Th1-cytokines, involved in the control of the pathogen 
propagation, and Th2 factors directing the pathological process 
in the intestinal mucosa. 
THE ROLE OF THE ADAPTIVE IMMUNITY 
A variety of studies have shown that both cellular and humoral 
acquired	 immunity	play	 a	 significant	 role	 in	 the	 control	 of	
cryptosporidiosis. Many of the reports are evaluating the 
severity of the clinical symptoms, oocyst production levels 
and the outcome of the cryptosporidiosis in animal (murine) 
lines with selected mutations leading to singular or combined 
T-cells	deficiencies.	The	observation	of	the	same	parameters	
in the clinical cases of patients with AIDS and other types of 
primary	 immunodeficiencies	may	 confirm	 the	 conclusions	
from animal testing but sometimes raises even more questions.
Numerous experiments have demonstrated that infection 
of C. parvum and C. muris	elicits	an	antigen-specific	immune	
response in the T-lymphocytes. The proliferation and cytokine 
production of lymphocytes from the spleen, MNs or peripheral 
blood from previously infected animals commence rapidly 
when the former are cultured with Cryptosporidium oocysts of 
the	specific	species	(40,	41).	Studies	of	immuno-naive	SCID	
mice	show	similar	results.	The	immuno-deficient	mice	manage	
to	fight	off	C. parvum or C. muris infection after the transfer 
of different T-lymphocyte populations from immunocompetent 
(pre-infected with the same species) animals (42).
Histological studies in healthy volunteers, patients with 
AIDS and cryptosporidiosis and experimental models have 
shown that the C. parvum infection leads to an upsurge in the 
number of T-lymphocytes subsets in the intestinal mucosa 
(43,	 44)	 and	 substantial	 intensification	 in	 the	 production	
of	 proinflammatory	 cytokines	 (36).	As	 cryptosporidiosis	
subsides, the number of T-cells in the intestinal lining declines 
to	 the	normal	 levels	 (6).	The	first	study	 to	demonstrate	 the	
essential role of T-cells in the control of Cryptosporidium 
infection is in athymic mice (45). In the wild neonate animals, 
cryptosporidiosis was acute but rapid and self-limiting. In 
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T-cell	deficient	mice,	on	 the	other	hand,	 the	disease	 took	a	
chronic course and was fatal in many cases (45). Similar 
persistent	infection	was	demonstrated	in	the	first	experiments	
with SCID mice infected with C. parvum and C. Muris (17, 
19). Furthermore, the experimental depletion of T-lymphocytes 
prevented recovery from Cryptosporidium infection in 
immunocompetent mice (4).
Countless epidemiological studies of cryptosporidiosis 
in	 humans	 confirm	 that	 the	 incidence	 of	 cryptosporidiosis	
with a diverse and deteriorating clinical presentation is 
higher in immunosuppressed patients (either suffering from 
a viral infection like HIV or due to immunosuppressive 
chemotherapies for a malignant process, or bone marrow/solid 
organ transplantation). In such cases, the diarrhoea persists 
for months, and the infection can involve extraintestinal sites 
(bile ducts, pancreas, respiratory system) and is lethal in some 
cases (1,4,25). 
The utmost association of chronic and life-threatening 
cryptosporidiosis, usually with hepato-biliary involvement, is 
observed in patients with X-linked hyper-IgM syndrome. This 
primary	immunodeficiency	is	caused	by	a	specific	mutation	in	
one of the costimulatory molecules (CD40L) of the T-cells that 
activate IL-12 production by antigen-presenting cells and B-cell 
differentiation	(1,	46,	47).	Other	primary	immunodeficiencies	
that are susceptible to Cryptosporidium infection include 
primary	CD4+	 lymphopenia,	 IFN-γ	 deficiency	 and	 severe	
combined	immunodeficiency	syndrome	(5).	
Extensive research in the previous decades has shown that 
the control of the cryptosporidiosis in humans depends on 
the	lymphocytes	with	the	αβ-form	of	T-cell	receptors	while	
the	 role	of	 the	T-cells	with	 γδ-receptors	 (even	 though	 they	
are in higher number in the mucosa) is secondary or even 
irrelevant (6). Additionally, the properly functioning subset 
of CD4+ lymphocytes is essential for the resistance to the 
Cryptosporidium infection. CD8+ T-cells are subordinate and 
play minor regulatory roles (1, 6, 42).
One of the main pieces of evidence for the fundamental 
role of CD4+ T-lymphocytes in the resistance against 
cryptosporidiosis is the increased susceptibility to the disease 
and its severe forms in patients with active AIDS, in whom 
the	specific	pathogenic	effect	of	the	HIV-virus	significantly	
reduced the CD4+ cell population. Cryptosporidiosis usually 
is a self-limiting infection, even in HIV+ patients, when the 
CD4+ T-cell count exceeds 180 cells/l. If CD4-cell levels 
reach 100 cells/l cryptosporidiosis takes a chronic course 
and becomes fulminant, atypical and lethal when counts drop 
below 50 cells/l (1, 7, 48, 49). Moreover, since the start of 
the application of the HAART, that leads to the restoration of 
CD4+ cell levels, cryptosporidiosis cases in this group have 
declined	significantly,	and	even	if	the	infection	occurs,	it	is	
controlled very swiftly (1, 4, 7, 25, 50). This phenomenon 
directly correlates with the increase of the number of CD4+ 
T-lymphocytes in the intestinal mucosa (25).
The earliest experimental immunological studies of the 
disease demonstrate the critical role of the CD4+ cells in the 
course of the Cryptosporidium infection. In immunocompetent 
mice infected with C. parvum or C. muris inoculation with 
anti-CD4 antibodies depleting the CD4+ T-lymphocyte 
population, leads to clinical deterioration (42). On the 
contrary, in SCID mice, the inoculation with lymphocytes from 
immunocompetent animals provides adequate resistance to the 
infection. The disease, however, is not limited if the introduced 
cell line does not contain CD4+ T-cells (18, 42).
CD8+ T-cell numbers also increase in the affected intestinal 
sections. Their role is still unclear, and several experiments 
show that they are not essential for the resistance against the 
Cryptosporidium	infection.	In	murine	lines	with	MHC-I	deficit	
and total lack of CD8+ T- lymphocytes, the elimination of 
C. parvum is commensurable with the observations in wild 
controls	without	immunodeficiency	(51).	In	C. muris-infected 
mice, inoculation with anti-CD8 antibodies facilitates the 
parasite reproduction but not as much as when anti-CD4 
antibodies are used (42). The current consensus is that CD8+ 
T-lymphocytes probably participate in the resistance against 
Cryptosporidium infection, but their role is regulatory and 
supplemental (4, 7)
Several	recent	reports,	however,	cast	doubt	on	the	significant	
protective impact of CD4+ T-cells against cryptosporidiosis, 
especially in newborns. In neonate murine models no 
considerable growth in the levels of CD4+ (and CD8+) T-cells 
was observed during C. parvum infection, neither in the 
Peyer’s patches nor in lamina propria (52, 53). Furthermore, 
treatment of newborn mice with anti-CD4 neutralising 
antibodies had no notable effect on the susceptibility to 
infection	 (53).	These	findings	 support	 the	 concept	 that	 the	
processes of innate and adaptive immunity in the course of 
cryptosporidiosis are age-dependent as demonstrated by the 
highest frequency and severity of the disease in animal and 
human newborns alike (1, 54). 
The evidence for the importance of humoral immunity for 
the control of Cryptosporidium infection is contradictory. 
Biopsy materials from experimentally infected volunteers 
44
Biomed Rev 30, 2019
Stoyanova and Pavlov
give	evidence	 that	B-lymphocytes	are	one	of	 the	first	cells	
recruited to the site of infection. In lamina propria, their 
amount	increased	significantly	as	early	as	day	3,	and	antibody-
producing B-cells appeared in the peripheral circulation on 
day	five	 and	 remained	 for	 several	weeks	 (7).	Regrettably,	
most	 of	 the	 experiments	 on	B-cell	 deficient	murine	 lines	
show that, despite the rapid activation of these lymphocytes, 
the antibodies play a relatively small role in eliminating the 
infection	 (6,	7).	There	 is	not	a	 significant	difference	 in	 the	
course of cryptosporidiosis in SCID mice that underwent 
immune reconstruction with non-B-cell mucosal lymphocytes, 
compared to the lines where the recovery was achieved with 
lymphocytes from all cell populations (42). Similar results are 
reported in transgenic mice with congenital absolute B-cell 
deficiency	where	 the	 severity	 of	 the	 disease	 and	 the	 time	
to elimination of the cryptosporidiosis are not substantially 
different as compared to the healthy controls (55).
The B-cells of the infected organism synthesise serum 
antibodies against various soluble membrane-associated 
proteins of the Cryptosporidium sporozoites - IgG (against 
17-, 27-, and 15-kDa proteins), IgM (against 27-kD antigens) 
and IgA (predominantly against 17 kD proteins) (7, 56). 
The	 immunoglobulins	 are	 not	 species-specific	 but	 target	
Cryptosporidia of the entire genus and as proven by Priest 
et al. (57) in healthy volunteers infected with C. hominis, C. 
parvum, C. felis and C. meleagridis. 
Various studies on the immune response and seroconversion 
in cryptosporidiosis demonstrate that increased levels of IgM 
and IgG synthesised in the previous infections have a partial 
protective effect. They mainly prevent the development of 
disease with pronounced clinical features but do not counteract 
the re-infection. Other experiments have linked the presence 
of IgG antibodies from previous exposure with the reduction 
of oocysts shedding upon re-infection (58, 59). The protective 
effect of the immunity developed after the initial infection is 
also	indirectly	confirmed	by	a	majority	of	serological	epidemic	
studies. These demonstrate that local population in certain 
regions suffers less from cryptosporidiosis in comparison to 
new arrivals, the elderly less than children, and the ones who 
consume	 insufficiently	 purified	water,	 less	 than	 those	with	
access to effectively disinfected water sources (58–60). 
Mucosal IgA is considered the lead factor in protecting 
epithelial tissues against microbial agents. In murine 
experimental studies, Albert et al. (61) manage to transfer 
passive protection against C. parvum, by inoculating 
immunodeficient	lines	with	bile	derived	IgA	from	self-cured	
animals. Partial protection in newborn mice against C. parvum 
is demonstrated after inoculation with monoclonal IgA from 
B-lymphocytes from previously infected animals (62). IgA 
may contribute to the cellular response by coating the surface 
of the sporozoites and merozoites and averting the attachment 
and penetration into the epithelial cells (5). Several clinical 
cases of severe and persistent diarrhoea in patients with a 
congenital	selective	deficiency	in	the	IgA-synthesis	confirm	its	
importance in the defence against cryptosporidiosis (63, 64).
The results from studies that evaluate the role of passive 
immunity in Cryptosporidium infection are inconsistent. 
Experiments	 with	 newborn	 calves	 confirm	 the	 passive	
transmission of antibodies and reduced severity of diarrhoea 
and parasite reproduction after oral administration of 
concentrated serum containing anti-Cryptosporidium 
antibodies (3). This is especially true when the experiments 
are conducted with hyperimmune colostrum derived from 
animals	 previously	 injected	with	 purified	 oocyst	 antigens	
(3). Some epidemiological studies in humans suggest that 
cryptosporidiosis is less common in breastfed infants (65, 66), 
but	others	do	not	observe	significant	differences	(67).	
Overall, the results regarding the protective role of the 
B-cells and associated humoral immune response in the 
presence of Cryptosporidium infection are contradictory. The 
specific	antibodies	may	have	some	(however	minimal)	capacity	
to	reduce	parasitic	reproduction,	but	do	not	play	a	significant	
role in the immunological control of the disease and do not 
prevent re-infection. This results in another critical problem 
in the clinical practice: the serological tests are irrelevant and 
not useful for the routine diagnosis of cryptosporidiosis.
CONCLUSION
The immune response against infection by Cryptosporidium 
spp. includes all strata of innate and adaptive immunity with 
differences	 in	 their	 significance.	The	 innate	mechanisms	
of the intestinal mucosa (mucosal immunity), expressed 
predominantly by the “sentinel” role of epitheliocytes, are 
fundamental to the defence against this disease (Fig. 1). The 
vast array of epithelial chemokines and cytokines initiate 
the	local	inflammatory	processes,	attract	other	effector	cells	
and directly inactivate the parasite adhesion. The second line 
of	 defence	 includes	 IFN-γ-production	 by	 the	NK	 cells	 in	
combination with their innate cytotoxicity against the parasite 
and the infected epitheliocytes. The next level of resistance is 
the	cell-mediated	immunity	with	the	significant	participation	
of CD4+ T-lymphocytes, aided and regulated to some extent 
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by	CD8+	cells.	IFN-γ	and	other	proinflammatory	cytokines	
act directly on the infected enterocytes or activate a variety 
of immunocompetent cells. Even if some of the following 
effects are explained and experimentally proven, the vast 
amount of the interaction between mediators and cells is still 
under research. Cryptosporidium infection subsequently leads 
to	the	synthesis	of	specific	serum	and	mucosal	antibodies	by	
the B-cells, but for now, the humoral immunity is considered 
to be of secondary and minor importance.
Despite	the	difficulties	in	conducting	experimental	studies	
in	the	fields	of	Cryptosporidium immunology (working either 
with cell cultures or with animal models) their realisation 
and	 implementation	 in	 the	 future	 is	 scientifically	 justified	
and of great practical importance. While the infection with 
Cryptosporidium spp. in immunocompetent individuals 
is mainly mild and asymptomatic, their role as one of 
the major opportunistic pathogens causing severe to life-
threatening diarrhoea will remain essential, both in children 
and in the continually expanding group of patients with 
immunodeficiencies	and	systemic	chronic	diseases.	Also,	these	
studies reveal essential data about some still poorly understood 
mechanisms	of	mucosal	immunity.	These	findings	can	further	
help to decipher the multicomponent immunological responses 
against other intestinal pathogens and reveal some of the 
pathogenetic mechanisms of autoimmune diseases of the 
intestinal mucosa.
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